

Author: PARKER TIMOTHY ZITELLI JOHN
Publisher: Elsevier
ISSN: 1076-0512
Source: Dermatologic Surgery, Vol.22, Iss.3, 1996-03, pp. : 234-240
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Mohs Surgery and Malignant Melanoma
Dermatologic Surgery, Vol. 21, Iss. 4, 1995-04 ,pp. :


Malignant Melanoma: Treatment in Evolution
Dermatologic Surgery, Vol. 21, Iss. 11, 1995-11 ,pp. :


Optimising immunotherapy for malignant melanoma
Inpharma, Vol. 1, Iss. 1262, 2000-01 ,pp. :


Epigenetic Lesions in Malignant Melanoma
Current Pharmaceutical Biotechnology, Vol. 8, Iss. 6, 2007-12 ,pp. :


Natalizumab: Malignant melanoma: case report
Reactions Weekly, Vol. 1, Iss. 1341, 2011-01 ,pp. :